BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22186994)

  • 1. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.
    Finney BA; Schweighoffer E; Navarro-Núñez L; Bénézech C; Barone F; Hughes CE; Langan SA; Lowe KL; Pollitt AY; Mourao-Sa D; Sheardown S; Nash GB; Smithers N; Reis e Sousa C; Tybulewicz VL; Watson SP
    Blood; 2012 Feb; 119(7):1747-56. PubMed ID: 22186994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.
    Pollitt AY; Poulter NS; Gitz E; Navarro-Nuñez L; Wang YJ; Hughes CE; Thomas SG; Nieswandt B; Douglas MR; Owen DM; Jackson DG; Dustin ML; Watson SP
    J Biol Chem; 2014 Dec; 289(52):35695-710. PubMed ID: 25368330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
    Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
    Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
    Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
    Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.
    Hughes CE; Finney BA; Koentgen F; Lowe KL; Watson SP
    Blood; 2015 Jan; 125(1):144-54. PubMed ID: 25352128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
    Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
    J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
    Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
    Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis.
    Kumode T; Tanaka H; Esipinoza JL; Rai S; Taniguchi Y; Fujiwara R; Sano K; Serizawa K; Iwata Y; Morita Y; Matsumura I
    Int J Hematol; 2022 Mar; 115(3):310-321. PubMed ID: 35106701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization.
    Lorenz V; Stegner D; Stritt S; Vögtle T; Kiefer F; Witke W; Schymeinsky J; Watson SP; Walzog B; Nieswandt B
    Blood; 2015 Jun; 125(26):4069-77. PubMed ID: 25795918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
    Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
    Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow.
    Nakamura-Ishizu A; Takubo K; Kobayashi H; Suzuki-Inoue K; Suda T
    J Exp Med; 2015 Nov; 212(12):2133-46. PubMed ID: 26552707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.
    Séverin S; Pollitt AY; Navarro-Nuñez L; Nash CA; Mourão-Sá D; Eble JA; Senis YA; Watson SP
    J Biol Chem; 2011 Feb; 286(6):4107-16. PubMed ID: 21098033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade.
    Fuller GL; Williams JA; Tomlinson MG; Eble JA; Hanna SL; Pöhlmann S; Suzuki-Inoue K; Ozaki Y; Watson SP; Pearce AC
    J Biol Chem; 2007 Apr; 282(17):12397-409. PubMed ID: 17339324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC-2 is required for development and maintenance of lymph nodes.
    Bénézech C; Nayar S; Finney BA; Withers DR; Lowe K; Desanti GE; Marriott CL; Watson SP; Caamaño JH; Buckley CD; Barone F
    Blood; 2014 May; 123(20):3200-7. PubMed ID: 24532804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of Src-Syk-PLC{gamma}2 signaling in megakaryocyte migration and thrombopoiesis.
    Mazharian A; Thomas SG; Dhanjal TS; Buckley CD; Watson SP
    Blood; 2010 Aug; 116(5):793-800. PubMed ID: 20457868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses.
    Mourão-Sá D; Robinson MJ; Zelenay S; Sancho D; Chakravarty P; Larsen R; Plantinga M; Van Rooijen N; Soares MP; Lambrecht B; Reis e Sousa C
    Eur J Immunol; 2011 Oct; 41(10):3040-53. PubMed ID: 21728173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
    Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
    Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC-2 activates Syk through dimerization.
    Hughes CE; Pollitt AY; Mori J; Eble JA; Tomlinson MG; Hartwig JH; O'Callaghan CA; Fütterer K; Watson SP
    Blood; 2010 Apr; 115(14):2947-55. PubMed ID: 20154219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
    Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
    J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.